Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.

ABSTRACT: Glioblastoma (GBM) is characterized by aggressive growth and high rates of recurrence. Despite the advancements in conventional therapies, the prognosis for GBM patients remains poor. Immunotherapy has recently emerged as a potential treatment option. The aim of this systematic review is to assess the current strategies and future perspectives of the GBM immunotherapy strategies. A systematic search was conducted across major medical databases (PubMed, Embase, and Cochrane Library) up to 3 September 2023. The search strategy utilized relevant Medical Subject Heading (MeSH) terms and keywords related to "glioblastomas," "immunotherapies," and "treatment." The studies included in this review consist of randomized controlled trials, non-randomized controlled trials, and cohort studies reporti

SUBMITTER: Agosti E 

PROVIDER: S-EPMC10606063 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature